within Pharmacolibrary.Drugs.ATC.G;

model G03FB04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 2.4999999999999998e-06,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 1200
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03FB04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Megestrol and estrogen is a fixed combination of megestrol, a progestin, and an estrogen used in hormone replacement therapy for menopausal symptoms. Its combination was previously used for treatment of menopausal complaints in women but is not commonly marketed or approved for use today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies are available characterizing the PK parameters of the fixed combination of megestrol and estrogen in humans. The following are estimated parameters based on known properties of oral megestrol acetate and conjugated estrogens in adult women.</p><h4>References</h4><ol><li><p>Lello, S (2010). Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy. <i>Drugs</i> 70(5) 541–559. DOI:<a href=\"https://doi.org/10.2165/11532130-000000000-00000\">10.2165/11532130-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20329803/\">https://pubmed.ncbi.nlm.nih.gov/20329803</a></p></li><li><p>Lamb, HM, &amp; Adkins, JC (1998). Letrozole. A review of its use in postmenopausal women with advanced breast cancer. <i>Drugs</i> 56(6) 1125–1140. DOI:<a href=\"https://doi.org/10.2165/00003495-199856060-00020\">10.2165/00003495-199856060-00020</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9878997/\">https://pubmed.ncbi.nlm.nih.gov/9878997</a></p></li><li><p>Mueck, AO, &amp; Sitruk-Ware, R (2011). Nomegestrol acetate, a novel progestogen for oral contraception. <i>Steroids</i> 76(6) 531–539. DOI:<a href=\"https://doi.org/10.1016/j.steroids.2011.02.002\">10.1016/j.steroids.2011.02.002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21335021/\">https://pubmed.ncbi.nlm.nih.gov/21335021</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03FB04;
